Innovent Biologics Inc (6IB) — Cash Flow Quality Index

Latest as of December 2025: 12.29x

Innovent Biologics Inc (6IB) has a Cash Flow Quality Index of 12.29x as of December 2025. Operating cash flow of €10.00 Billion exceeds net income of €813.57 Million, indicating high earnings quality where cash backs reported profits. Explore Innovent Biologics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

12.29x

Operating CF / Net Income

Operating Cash Flow

€10.00 Billion

EUR

Net Income

€813.57 Million

EUR

Data as of

Dec 2025

Most recent filing

Innovent Biologics Inc Cash Flow Quality Index (2025–2025)

Historical Cash Flow Quality Index for Innovent Biologics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Innovent Biologics Inc operating cash flow efficiency.

Annual Cash Flow Quality Index for Innovent Biologics Inc (2025–2025)

Year-by-year earnings quality comparison for Innovent Biologics Inc.

Year	Quality Index	Operating CF (EUR)	Net Income	YoY Change
2025	12.29x	€10.00 Billion	€813.57 Million	—

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.